# Fluorouracil Treatment Via Colon for Colorectal Cancer

Source: https://onco.cc/trials/nct06385418/  
OnCo record `nct06385418` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial in colorectal cancer, run by The Second Hospital of Nanjing Medical University, now recruiting.

## Summary

Fluorouracil Treatment Via Colon for Colorectal Cancer is a phase 2, interventional study registered as NCT06385418 by The Second Hospital of Nanjing Medical University, with a registry enrolment figure of 40 participants, started 2024-05-16 and due to reach its primary completion in 2028-05-01. Interventions recorded: Colonic local administration of fluorouracil with enhanced adhesion. Conditions listed: Colorectal Cancer. Primary outcome: Objective response rate (according to RECIST1.1, investigator assessment). Colorectal eligibility wording from the registry: "Histologically confirmed diagnosis of colorectal cancer with measurable primary lesion according to RECIST 1". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; colorectal-deep-dive
- Registry id: NCT06385418
- Phase: 2
- Setting: Fluorouracil Treatment Via Colon for Colorectal Cancer: an Exploratory Study
- Sponsor: The Second Hospital of Nanjing Medical University
- Enrolled: 40

## Sources

- ClinicalTrials.gov NCT06385418: https://clinicaltrials.gov/study/NCT06385418

## Connected records

- cancers: [Colon cancer (adenocarcinoma of the colon)](https://onco.cc/cancers/colon-cancer/)
- terms: [Colorectal cancer trials open today (registry snapshot)](https://onco.cc/terms/colorectal-trials-open-today/)

---
JSON: https://onco.cc/api/v1/entities/nct06385418.json